Literature DB >> 2171457

Production and characterization of a fragment containing the HIV-gp120 binding region of CD4 using a bovine papilloma virus (BPV) vector.

M Gidlund1, M Sydow, A Stenbeck, P Flodby, H Fossum, S Matsuda, K Lundin, H Wigzell, P Lind.   

Abstract

We have used a bovine papilloma virus (BPV) based mammalian cell expression vector consisting of the complete BPV genome and a human cytomegalovirus transcription unit for the production of soluble CD4. Mouse C-127 cells were transfected with vector DNA together with a selectable G418 resistance plasmid. Surviving clones were selected for high production using a solid phase ELISA based on the immobilization of supernatant-derived CD4 onto nitrocellulose paper and subsequent detection with anti-CD4 antibodies. The expressed protein was shown to bind HIV-gp120 and efficiently block HIV-1 infection in vitro. The possibility to use the above system for rapid production of defined glycoprotein fragments harboring defined functional regions, for the further elucidation of the functional role of CD4 in antigen presentation and cell to cell contact, and for possible intervention during HIV infection is discussed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2171457     DOI: 10.1007/BF01316674

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  23 in total

1.  Cystein 402 of HIV gp 120 is essential for CD4-binding and resistance of gp 120 to intracellular degradation.

Authors:  A Hemming; A Bolmstedt; P Flodby; L Lundberg; M Gidlund; H Wigzell; S Olofsson
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

2.  Soluble CD4 molecules neutralize human immunodeficiency virus type 1.

Authors:  A Traunecker; W Lüke; K Karjalainen
Journal:  Nature       Date:  1988-01-07       Impact factor: 49.962

3.  Interaction between the human T-cell lymphotropic virus type IIIB envelope glycoprotein gp120 and the surface antigen CD4: role of carbohydrate in binding and cell fusion.

Authors:  T J Matthews; K J Weinhold; H K Lyerly; A J Langlois; H Wigzell; D P Bolognesi
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

4.  Infection of HTLV-III/LAV in HTLV-I-carrying cells MT-2 and MT-4 and application in a plaque assay.

Authors:  S Harada; Y Koyanagi; N Yamamoto
Journal:  Science       Date:  1985-08-09       Impact factor: 47.728

5.  The isolation and nucleotide sequence of a cDNA encoding the T cell surface protein T4: a new member of the immunoglobulin gene family.

Authors:  P J Maddon; D R Littman; M Godfrey; D E Maddon; L Chess; R Axel
Journal:  Cell       Date:  1985-08       Impact factor: 41.582

6.  Functional interaction between human T-cell protein CD4 and the major histocompatibility complex HLA-DR antigen.

Authors:  D Gay; P Maddon; R Sekaly; M A Talle; M Godfrey; E Long; G Goldstein; L Chess; R Axel; J Kappler
Journal:  Nature       Date:  1987 Aug 13-19       Impact factor: 49.962

7.  Evidence for a physical association of CD4 and the CD3:alpha:beta T-cell receptor.

Authors:  K Saizawa; J Rojo; C A Janeway
Journal:  Nature       Date:  1987 Jul 16-22       Impact factor: 49.962

8.  Transformation and replication in mouse cells of a bovine papillomavirus--pML2 plasmid vector that can be rescued in bacteria.

Authors:  N Sarver; J C Byrne; P M Howley
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

9.  A quantitative dot-immunobinding assay for proteins using nitrocellulose membrane filters.

Authors:  R Jahn; W Schiebler; P Greengard
Journal:  Proc Natl Acad Sci U S A       Date:  1984-03       Impact factor: 11.205

10.  Location and chemical synthesis of a binding site for HIV-1 on the CD4 protein.

Authors:  B A Jameson; P E Rao; L I Kong; B H Hahn; G M Shaw; L E Hood; S B Kent
Journal:  Science       Date:  1988-06-03       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.